Opin vísindi

Fletta eftir höfundi "Björnsson, Einar Stefán"

Fletta eftir höfundi "Björnsson, Einar Stefán"

Röðun: Raða: Niðurstöður:

  • Helgadóttir, Hólmfríður; Björnsson, Einar Stefán (2023-07-01)
    Ágrip Prótónpumpuhemlar eru öflug sýruhemjandi lyf og tilkoma þeirra hefur gjörbylt meðferð sýrutengdra sjúkdóma. Helstu og almennt viðurkenndu ábendingar fyrir notkun þeirra er meðferð við bakflæði og sárasjúkdómi í meltingarvegi, uppræting Helicobacter ...
  • Hayashi, Paul H; Lucena, M Isabel; Fontana, Robert J; Björnsson, Einar Stefán; Aithal, Guruprasad P; Barnhart, Huiman; Gonzalez-Jimenez, Andres; Yang, Qinghong; Gu, Jiezhun; Andrade, Raul J; Hoofnagle, Jay H (2022-07)
    BACKGROUND AND AIMS: Roussel Uclaf Causality Assessment Method (RUCAM) for DILI has been hindered by subjectivity and poor reliability. We sought to improve the RUCAM using data from the Drug-Induced Liver Injury Network (DILIN) and the Spanish DILI ...
  • Lucena, M I; Villanueva-Paz, M; Alvarez-Alvarez, I; Aithal, G P; Björnsson, Einar Stefán; Cakan-Akdogan, G; Cubero, F J; Esteves, F; Falcon-Perez, J M; Fromenty, B; Garcia-Ruiz, C; Grove, J I; Konu, O; Kranendonk, M; Kullak-Ublick, G A; Miranda, J P; Remesal-Doblado, A; Sancho-Bru, P; Nelson, L; Andrade, R J; Daly, A K; Fernandez-Checa, J C (2024-02)
    In the current article the aims for a constructive way forward in Drug-Induced Liver Injury (DILI) are to highlight the most important priorities in research and clinical science, therefore supporting a more informed, focused, and better funded future ...
  • Björnsson, Einar Stefán; Vucic, Vesna; Stirnimann, Guido; Robles-Díaz, Mercedes (2022-02-10)
    Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DILI), there is no standard therapy for DILI. Corticosteroids have been used in DILI, although their efficacy is unclear. Published data showed either ...
  • Robles-Díaz, Mercedes; Nezic, Lana; Vujic-Aleksic, Vesna; Björnsson, Einar Stefán (2021-10-27)
    Introduction: Treatment is generally not available for drug-induced liver injury (DILI) patients except in some specific circumstances. The management of DILI is based on the withdrawal of the responsible drug and monitoring the patients and only a few ...
  • Ravindra, Kodihalli C; Vaidya, Vishal S; Wang, Zhenyu; Federspiel, Joel D; Virgen-Slane, Richard; Everley, Robert A; Grove, Jane I; Stephens, Camilla; Ocana, Mireia F; Robles-Díaz, Mercedes; Isabel Lucena, M; Andrade, Raul J; Atallah, Edmond; Gerbes, Alexander L; Weber, Sabine; Cortez-Pinto, Helena; Fowell, Andrew J; Hussaini, Hyder; Björnsson, Einar Stefán; Patel, Janisha; Stirnimann, Guido; Verma, Sumita; Elsharkawy, Ahmed M; Griffiths, William J H; Hyde, Craig; Dear, James W; Aithal, Guruprasad P; Ramaiah, Shashi K (2023-03-03)
    Diagnosis of drug-induced liver injury (DILI) and its distinction from other liver diseases are significant challenges in drug development and clinical practice. Here, we identify, confirm, and replicate the biomarker performance characteristics of ...
  • Robles-Díaz, Mercedes; Sanabria-Cabrera, Judith; Björnsson, Einar Stefán (2022)